<?xml version="1.0" encoding="UTF-8"?>
<p id="Par41">Nineteen different 
 <italic>OPRM1</italic> spliced variants have been described in humans (Pasternak 
 <xref ref-type="bibr" rid="CR379">2004</xref>, 
 <xref ref-type="bibr" rid="CR380">2014</xref>; Xu et al. 
 <xref ref-type="bibr" rid="CR551">2014a</xref>; Lu et al. 
 <xref ref-type="bibr" rid="CR298">2015</xref>). 
 <italic>OPRM1</italic> alternative splicing may also influence susceptibility to HIV-1 infection (Dever et al. 
 <xref ref-type="bibr" rid="CR114">2012</xref>, 
 <xref ref-type="bibr" rid="CR115">2014</xref>). Although many variants are thought to be non-functional and fail to traffic from the endoplasmic reticulum, increasing evidence suggests they may oligomerize other G Protein-coupled receptors or bind chaperones to assist in trafficking to the plasma membrane (Samoshkin et al. 
 <xref ref-type="bibr" rid="CR449">2015</xref>; Zhu et al. 
 <xref ref-type="bibr" rid="CR559">2019</xref>). Quantitative and qualitative differences in human MOR splice variant expression levels have been noted across different CNS cell types following exposure to HIV (Dever et al. 
 <xref ref-type="bibr" rid="CR114">2012</xref>, 
 <xref ref-type="bibr" rid="CR115">2014</xref>). Interestingly, an excitatory, MOR-1 K splice variant, that couples to Gα
 <sub>S</sub> (Gris et al. 
 <xref ref-type="bibr" rid="CR190">2010</xref>) is preferentially expressed in human astroglia (Dever et al. 
 <xref ref-type="bibr" rid="CR114">2012</xref>) and has been shown to correlate with HIVE and cognitive impairment (Dever et al. 
 <xref ref-type="bibr" rid="CR114">2012</xref>, 
 <xref ref-type="bibr" rid="CR115">2014</xref>).
</p>
